| scholarly article | Q13442814 |
| P2093 | author name string | A S Verkman | |
| Scott D Casey | |||
| Marc H Levin | |||
| Christian M Felix | |||
| Alyssa M Flores | |||
| Puay W Phuan | |||
| P2860 | cites work | Prevalence of dry eye syndrome among US women | Q28196875 |
| Aquaporin-dependent water permeation at the mouse ocular surface: in vivo microfluorimetric measurements in cornea and conjunctiva | Q28506507 | ||
| Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds | Q30659857 | ||
| Green fluorescent protein-based halide indicators with improved chloride and iodide affinities | Q30993765 | ||
| Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements | Q33643019 | ||
| Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies | Q33720070 | ||
| Diuresis and reduced urinary osmolality in rats produced by small-molecule UT-A-selective urea transport inhibitors. | Q34072644 | ||
| Changes of chloride channels in the lacrimal glands of a rabbit model of Sjögren syndrome | Q34096334 | ||
| The economic burden of dry eye disease in the United States: a decision tree analysis | Q34147677 | ||
| CFTR-mediated Cl(-) transport in the acinar and duct cells of rabbit lacrimal gland | Q34266487 | ||
| Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis | Q34748891 | ||
| A CFTR potentiator in patients with cystic fibrosis and the G551D mutation | Q35591553 | ||
| Diquafosol tetrasodium: a novel dry eye therapy | Q35609725 | ||
| Triazolothienopyrimidine inhibitors of urea transporter UT-B reduce urine concentration | Q36050904 | ||
| Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency | Q36120878 | ||
| A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients | Q36296284 | ||
| Regional differences in rat conjunctival ion transport activities | Q36312382 | ||
| Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye. | Q37139290 | ||
| Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. | Q38120327 | ||
| Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists | Q40774846 | ||
| Activation of a CFTR-mediated chloride current in a rabbit corneal epithelial cell line | Q40783049 | ||
| Comparison of conjunctival and corneal surface areas in rabbit and human | Q41278539 | ||
| CFTR-regulated chloride transport at the ocular surface in living mice measured by potential differences | Q42476061 | ||
| Cyclic AMP-dependent stimulation of basolateral K(+)conductance in the rabbit conjunctival epithelium | Q42484831 | ||
| Potential difference measurements of ocular surface Na+ absorption analyzed using an electrokinetic model | Q42676900 | ||
| Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study | Q42708147 | ||
| Characterization of cyclic AMP-regulated chloride conductance in the pigmented rabbit conjunctival epithelial cells | Q44063629 | ||
| High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening | Q44088965 | ||
| Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. | Q45122469 | ||
| Production of a severe cystic fibrosis mutation in mice by gene targeting | Q45868497 | ||
| A link between tear instability and hyperosmolarity in dry eye. | Q46072952 | ||
| Active chloride transport in the pigmented rabbit conjunctiva | Q46105048 | ||
| Extraorbital lacrimal gland excision: a reproducible model of severe aqueous tear-deficient dry eye disease. | Q50459535 | ||
| Morphologic effect of hyperosmolarity on rabbit corneal epithelium. | Q52501417 | ||
| Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye. | Q53486933 | ||
| Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
| Ocular findings in cystic fibrosis patients receiving vitamin A supplementation | Q58816595 | ||
| Ophthalmologist Perceptions Regarding Treatment of Moderate-to-Severe Dry Eye: Results of a Physician Survey | Q61759590 | ||
| Conjunctival goblet cell density in normal subjects and in dry eye syndromes | Q66919524 | ||
| Tear sodium, potassium, chloride, and calcium at various flow rates: children with cystic fibrosis and unaffected siblings with and without corneal staining | Q70001012 | ||
| Cl- secretagogues increase basolateral K+ conductance of frog corneal epithelium | Q70361708 | ||
| Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? | Q77425439 | ||
| Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice | Q79350933 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| IL-8 and IFN-gamma in tear fluid of patients with cystic fibrosis | Q82598340 | ||
| Tear osmolarity in the diagnosis and management of dry eye disease | Q83395082 | ||
| Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye | Q86904838 | ||
| Presence of CFTR in the conjunctival epithelium | Q94075927 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1789-1797 | |
| P577 | publication date | 2016-02-03 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease | |
| P478 | volume | 30 |
| Q51313072 | Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins. |
| Q55185820 | Cellular mechanism for herbal medicine Junchoto to facilitate intestinal Cl-/water secretion that involves cAMP-dependent activation of CFTR. |
| Q38715239 | High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators. |
| Q91620982 | Interpreting an apoptotic corpse as anti-inflammatory involves a chloride sensing pathway |
| Q33752165 | Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases |
| Q47228449 | Novel Insight Into the Role of CFTR in Lacrimal Gland Duct Function in Mice |
| Q41615871 | Pro-Secretory Activity and Pharmacology in Rabbits of an Aminophenyl-1,3,5-Triazine CFTR Activator for Dry Eye Disorders |
| Q48593751 | Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice. |
Search more.